Mostly Markets
Subscribe
Stocks/Health Care/Health Care Equipment

GE HealthCareGEHC

Health Care Equipment · Chicago, Illinois · In the S&P 500
Solid businessCheaper than peers
$76.57+0.20%After hours: $76.21 (−0.47%)At the close, 30 Oct · Prices from CNBC, may be delayed
▼ 1.0% over 1 year
GE HealthCare over 1 yearDaily close, $, to 30 Oct 2026
$60$70$80Nov2026MarMayJulSep$76.57$60$80NovMarJul$76.57
Source: Nasdaq daily closes
Market value$34.62B
Price to earnings16.2x
Forward P/E14.9x
Dividend yield0.21%
Year to date−6.6%
One year−1.0%
Next earningsNot scheduled
SectorHealth Care
52-week range (closes)
$59.48$88.16

Quality and valuation

How GE HealthCare compares with other health care stocks. A description, not a recommendation.

GE HealthCare and 7 health care equipment peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.

Business quality: about averageValuation: cheaper than most

An average business among health care companies, priced below most of them.

GE HealthCare trades at 14.9 times the next 12 months of expected earnings, against a median of 19.1x for the 65 health care stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.

  • Revenue grew slower than the sector median: +6.9% vs +7.8%
  • Keeps less of each sale (gross margin): 39.9% vs 65.3%
  • Less profitable (operating margin): 13.3% vs 13.3%
  • Turns less of its sales into cash: 8.7% vs 15.9%
GEHC trades at 14.9x forward earnings, below the sector medianForward p/e, Health Care Equipment peers
BSX13.8xGEHC14.9xBDX15.0xMDT16.1xSYK18.4xABT18.6xEW29.3xISRG37.5xSector median 19.1xBSX13.8xGEHC14.9xBDX15.0xMDT16.1xSYK18.4xABT18.6xEW29.3xISRG37.5xSector median 19.1x
Source: CNBC quotes; Mostly Markets
At 16.1x earnings, GEHC is cheaper than its average since Oct 2024Price over the last 12 months of reported (GAAP) diluted EPS
P/EUsual range (±1 s.d.)
15x20xAverage 17.1x2025202616.1x15x20xAverage 17.1x2025202616.1x
Source: Nasdaq prices; SEC filings

Financials

From GE HealthCare's SEC filings, through the quarter ending 30 Sep 2026. Hover or tap a bar for its value.

Revenue grew 7.2% from a year earlierQuarterly revenue, $bn, latest Q3 ’26
$0bn$2bn$4bnQ4 ’24Q2 ’25Q4 ’25$5.5bnQ3 ’26$0bn$2bn$4bnQ4 ’24Q2 ’25Q4 ’25$5.5bnQ3 ’26
Source: SEC filings
Growth sped up to +7.2% last quarterRevenue growth, year on year, %
0%2%4%6%Q4 ’24Q2 ’25Q4 ’257.2%Q3 ’260%2%5%Q4 ’24Q2 ’25Q4 ’257.2%Q3 ’26
Source: SEC filings
Operating margin was 14.6% last quarterOperating income as a share of revenue, %
0%5%10%15%Q4 ’24Q2 ’25Q4 ’2514.6%Q3 ’260%10%Q4 ’24Q2 ’25Q4 ’2514.6%Q3 ’26
Source: SEC filings
Free cash flow was $1.9 billion over 12 monthsQuarterly free cash flow (operating cash flow minus capex), $m
$0m$250m$500m$750mQ4 ’24Q2 ’25Q4 ’25$793mQ3 ’26$0m$500mQ4 ’24Q2 ’25Q4 ’25$793mQ3 ’26
Source: SEC filings
Last 12 monthsGEHCSector median
Revenue growth+6.9%+7.8%
Gross margin39.9%65.3%
Operating margin13.3%13.3%
Free cash flow margin8.7%15.9%
Price to earnings16.2x30.2x

Stories on GE HealthCare

We haven't written about GE HealthCare yet. Follow it, and its first story will show under My stocks on the front page.

Similar companies

Health Care Equipment, by market value.

CompanyPriceTodayYTDValue
ABTAbbott Laboratories$106.20+1.56%−15.2%$184B
ISRGIntuitive Surgical$432.01−3.73%−23.7%$150B
MDTMedtronic$96.54−0.59%+0.5%$123B
SYKStryker$291.86−6.38%−17.0%$112B
BSXBoston Scientific$41.98−1.66%−56.0%$60.84B
BDXBecton Dickinson$197.88−0.23%+27.4%$53.90B
EWEdwards Lifesciences$92.01−2.57%+7.9%$53.03B
IDXXIdexx Laboratories$551.21−4.30%−18.5%$43.42B